Background:
Identifying potentially modifiable risk factors is critically important for reducing the burden of chronic kidney disease. We sought to examine the association of body mass index (BMI) with kidney function decline in a cohort of young adults with preserved glomerular filtration at baseline.
Study Design:
Longitudinal cohort.
Setting & Participants:
2,839 black and white young adults with cystatin C-based estimated glomerular filtration rate (eGFRcys)>90mL/min/1.73m(2) taking part in the year-10 examination (in 1995-1996) of the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Predictor:
BMI, categorized as 18.5-24.9 (reference), 25.0-29.9, 30.0-39.9, and ≥40.0kg/m(2).
Outcomes:
Trajectory of kidney function decline, rapid decline (>3% per year), and incident eGFRcys <60mL/min/1.73m(2) over 10 years of follow-up.
Measurements:
GFRcys estimated from the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation for calibrated cystatin C at CARDIA years 10, 15, and 20.
Results:
At year 10, participants had a mean age of 35.1 years, median eGFRcys of 114mL/min/1.73m(2), and 24.5% had BMI≥30.0kg/m(2). After age 30 years, average eGFRcys was progressively lower with each increment in BMI after adjustment for baseline age, race, sex, hyperlipidemia, smoking status, and physical activity. Higher BMI category was associated with successively higher odds of rapid decline (for 25.0-29.9, 30.0-39.9, and ≥40.0kg/m(2), adjusted ORs were 1.50 [95% CI, 1.21-1.87], 2.01 [95% CI, 1.57-2.87], and 2.57 [95% CI, 1.67-3.94], respectively). 18 participants (0.6%) had incident eGFRcys<60mL/min/1.73m(2). In unadjusted analysis, higher BMI category was associated with incident eGFRcys<60mL/min/1.73m(2) (for 25.0-29.9, 30.0-39.9, and ≥40.0kg/m(2), ORs were 5.17 [95% CI, 1.10-25.38], 7.44 [95% CI, 1.54-35.95], and 5.55 [95% CI, 0.50-61.81], respectively); adjusted associations were no longer significant.
Limitations:
Inability to describe kidney function before differences by BMI category were already evident. Absence of data for measured GFR or GFR estimated from serum creatinine level.
Conclusions:
Higher BMI categories are associated with greater declines in kidney function in a cohort of young adults with preserved GFR at baseline. Clinicians should vigilantly monitor overweight and obese patients for evidence of early kidney function decline.
Citing Articles
Long-term trajectory of estimated glomerular filtration rate in ambulatory patients with type 2 diabetes and heart failure: clinical insights and prognostic implications.
Julian M, Codina P, Lupon J, Zamora E, Perez-Montes de Oca A, Domingo M
Cardiovasc Diabetol. 2025; 24(1):104.
PMID: 40045364
PMC: 11884049.
DOI: 10.1186/s12933-025-02632-9.
Drug Development in Pediatric Chronic Kidney Disease: A Review of Promising Treatments, Old Challenges, and New Strategies.
Kula A
Paediatr Drugs. 2025; .
PMID: 39928268
DOI: 10.1007/s40272-025-00684-8.
The association between the body roundness index and the risk of chronic kidney disease in US adults.
Zhang J, Yu X
Front Med (Lausanne). 2025; 11:1495935.
PMID: 39744532
PMC: 11688310.
DOI: 10.3389/fmed.2024.1495935.
Prevalence and progression of chronic kidney disease among adults undergoing creatinine testing in South African public healthcare facilities: a study leveraging data from South Africa's National Health Laboratory Service (NHLS).
Brennan A, Kileel E, Khoza S, Crowther N, Bor J, Fox M
BMJ Public Health. 2024; 2(1).
PMID: 39698394
PMC: 11654635.
DOI: 10.1136/bmjph-2023-000799.
Associations of physiologic subtypes based on HOMA2 indices of β-cell function and insulin sensitivity with the risk of kidney function decline, cardiovascular disease, and all-cause mortality from the 4C study.
Luo P, Li D, Guo Y, Meng X, Kan R, Pan L
Cardiovasc Diabetol. 2024; 23(1):401.
PMID: 39511523
PMC: 11546320.
DOI: 10.1186/s12933-024-02496-5.
Visceral fat and attribute-based medicine in chronic kidney disease.
Kataoka H, Nitta K, Hoshino J
Front Endocrinol (Lausanne). 2023; 14:1097596.
PMID: 36843595
PMC: 9947142.
DOI: 10.3389/fendo.2023.1097596.
Effect of a Telephone Health Coaching Intervention on Hypertension Control in Young Adults: The MyHEART Randomized Clinical Trial.
Hoppe K, Smith M, Birstler J, Kim K, Sullivan-Vedder L, LaMantia J
JAMA Netw Open. 2023; 6(2):e2255618.
PMID: 36735261
PMC: 9898821.
DOI: 10.1001/jamanetworkopen.2022.55618.
Kidney-Function Trajectories From Young Adulthood to Midlife: Identifying Risk Strata and Opportunities for Intervention.
Guiney H, Walker R, Broadbent J, Caspi A, Goodin E, Kokaua J
Kidney Int Rep. 2023; 8(1):51-63.
PMID: 36644353
PMC: 9831942.
DOI: 10.1016/j.ekir.2022.10.005.
Comparison of trend in chronic kidney disease burden between China, Japan, the United Kingdom, and the United States.
Wen H, Yang D, Xie C, Shi F, Liu Y, Zhang J
Front Public Health. 2022; 10:999848.
PMID: 36159316
PMC: 9499831.
DOI: 10.3389/fpubh.2022.999848.
Obesity Is a Risk Factor for Renal Dysfunction Following Persistent Proteinuria: An Observational Cohort Study.
Nagai K, Nakajima M, Yoshii S
JMA J. 2022; 5(2):270-274.
PMID: 35611220
PMC: 9090544.
DOI: 10.31662/jmaj.2021-0223.
Obesity and CKD in Sub-Saharan Africa: A Narrative Review.
Oluyombo R, Oguntade H, Soje M, Obajolowo O, Karim M
Kidney Med. 2022; 4(2):100403.
PMID: 35243313
PMC: 8861962.
DOI: 10.1016/j.xkme.2021.11.001.
Renal Cellular Autophagy in Obesity: Boon or Bane?.
Ghandriz R, Lerman L
Semin Nephrol. 2021; 41(4):349-357.
PMID: 34715964
PMC: 8562881.
DOI: 10.1016/j.semnephrol.2021.06.006.
Distribution of estimated glomerular filtration rate and determinants of its age dependent loss in a German population-based study.
Waas T, Schulz A, Lotz J, Rossmann H, Pfeiffer N, Beutel M
Sci Rep. 2021; 11(1):10165.
PMID: 33986324
PMC: 8119940.
DOI: 10.1038/s41598-021-89442-7.
Impact of visceral fat area in patients with chronic kidney disease.
Manabe S, Kataoka H, Mochizuki T, Iwadoh K, Ushio Y, Kawachi K
Clin Exp Nephrol. 2021; 25(6):608-620.
PMID: 33595731
DOI: 10.1007/s10157-021-02029-4.
Association Between Midlife Obesity and Kidney Function Trajectories: The Atherosclerosis Risk in Communities (ARIC) Study.
Yu Z, Grams M, Ndumele C, Wagenknecht L, Boerwinkle E, North K
Am J Kidney Dis. 2020; 77(3):376-385.
PMID: 32979415
PMC: 7904650.
DOI: 10.1053/j.ajkd.2020.07.025.
Risk of Kidney Dysfunction from Polypharmacy among Older Patients: A Nested Case-Control Study of the South Korean Senior Cohort.
Kang H, Hong S
Sci Rep. 2019; 9(1):10440.
PMID: 31320704
PMC: 6639333.
DOI: 10.1038/s41598-019-46849-7.
Carbohydrate-Rich Diet Is Associated with Increased Risk of Incident Chronic Kidney Disease in Non-Diabetic Subjects.
Nam K, An S, Joo Y, Lee S, Yun H, Jhee J
J Clin Med. 2019; 8(6).
PMID: 31167515
PMC: 6617052.
DOI: 10.3390/jcm8060793.
Adult weight gain accelerates the onset of breast cancer.
Azrad M, Blair C, Rock C, Sedjo R, Wolin K, Demark-Wahnefried W
Breast Cancer Res Treat. 2019; 176(3):649-656.
PMID: 31073792
PMC: 7214103.
DOI: 10.1007/s10549-019-05268-y.
The Association between Obesity Phenotypes and Early Renal Function Decline in Adults without Hypertension, Dyslipidemia, and Diabetes.
Choi J, Cho Y, Lee S, Jeong D, Lee J, Yi Y
Korean J Fam Med. 2019; 40(3):176-181.
PMID: 31072076
PMC: 6536908.
DOI: 10.4082/kjfm.18.0139.
Rationale and study design of the MyHEART study: A young adult hypertension self-management randomized controlled trial.
Johnson H, Sullivan-Vedder L, Kim K, McBride P, Smith M, LaMantia J
Contemp Clin Trials. 2019; 78:88-100.
PMID: 30677485
PMC: 6387836.
DOI: 10.1016/j.cct.2019.01.010.